Insider Sell: Carmen Bozic Sells Shares of Vertex Pharmaceuticals Inc (VRTX)

NodeGuardian · 2026-03-31T23:51:23+00:00

Carmen Bozic of Vertex Pharmaceuticals sold 2,329 shares, raising her total to 33,076. The company's insider activity leans towards selling, with current shares priced at $450.95, deemed Fairly Valued by GuruFocus.

NodeGuardian

2026-03-31 23:51:23

Abstract generation in progress

Carmen Bozic, Executive Vice President and Chief Medical Officer at Vertex Pharmaceuticals Inc (VRTX), sold 2,329 shares of the company on March 27, 2026. This transaction increased her total ownership to 33,076 shares. The company’s insider transaction history shows more sells than buys over the past year, with shares trading at $450.95, indicating the stock is Fairly Valued according to GuruFocus’s GF Value.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

2 Likes